Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during …
S Muto, T Matsubara, T Inoue, H Kitamura… - International Journal of …, 2023 - Springer
The prevalence of CKD may be higher in patients with cancer than in those without due to
the addition of cancer-specific risk factors to those already present for CKD. In this review …
the addition of cancer-specific risk factors to those already present for CKD. In this review …
Chapter 2: indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney …
H Nishiyama, T Inoue, Y Koizumi, Y Kobayashi… - International Journal of …, 2023 - Springer
This comprehensive review discusses the dosing strategies of cancer treatment drugs for
patients with impaired kidney function, specifically those with chronic kidney disease (CKD) …
patients with impaired kidney function, specifically those with chronic kidney disease (CKD) …
[HTML][HTML] Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022
M Yanagita, S Muto, H Nishiyama, Y Ando… - Clinical and …, 2024 - Springer
Background Burn patients often face a high risk of acute kidney injury (AKI) after severe burn
injuries, meanwhile epigallocatechin-3-gallate (EGCG) has been proven to be effective in …
injuries, meanwhile epigallocatechin-3-gallate (EGCG) has been proven to be effective in …
[HTML][HTML] Efficacy of Magnesium Supplementation in Cancer Patients Developing Hypomagnesemia Due to Anti-EGFR Antibody: A Systematic Review
T Kato, T Kawaguchi, T Funakoshi… - Cancer Diagnosis & …, 2024 - ncbi.nlm.nih.gov
Materials and Methods Three electronic databases were searched for articles published
until June 18, 2021. The main outcomes used were “anti-EGFR antibody” and …
until June 18, 2021. The main outcomes used were “anti-EGFR antibody” and …
[HTML][HTML] Mitochondrial Transplantation Alleviates Doxorubicin-Induced Toxicity in Rat Renal Cells
Background: Doxorubicin (DOX) is used in the treatment of various cancers and has good
effectiveness. However, its therapeutic use is limited due to its effects on various organs and …
effectiveness. However, its therapeutic use is limited due to its effects on various organs and …
[PDF][PDF] Major Update to Guidelines for Managing Kidney Injury during Anticancer Drug Therapy in Japan
T Wada - kidneynews.org
By Takehiko Wada Cancer encompasses a critical group of diseases with a profound impact
on life prognoses and affects half of the Japanese population during their lifetime. Over the …
on life prognoses and affects half of the Japanese population during their lifetime. Over the …